Meyka Pro banner
Bausch + Lomb Corporation

Bausch + Lomb Corporation Fundamental Analysis (NYSE: BLCO)

BLCO●NYSE
HealthcareMedical - Instruments & Supplies
$21.14
$0.18(0.84%)
U.S. Market opens in 15h 28m

Bausch + Lomb Corporation Fundamental Analysis (NYSE: BLCO)

Bausch + Lomb Corporation (NYSE: BLCO) shows moderate financial fundamentals with a PE ratio of -68.36, profit margin of -2.05%, and ROE of -1.73%. The company generates $5.4B in annual revenue with moderate year-over-year growth of 6.47%.

Key Strengths

PEG Ratio-0.75
Current Ratio1.56

Areas of Concern

ROE-1.73%
Operating Margin8.41%
We analyze BLCO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 24.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
24.1/100

We analyze BLCO's fundamental strength across five key dimensions:

Efficiency Score

Weak

BLCO struggles to generate sufficient returns from assets.

ROA > 10%
-0.80%

Valuation Score

Excellent

BLCO trades at attractive valuation levels.

PE < 25
-68.36
PEG Ratio < 2
-0.75

Growth Score

Moderate

BLCO shows steady but slowing expansion.

Revenue Growth > 5%
6.47%
EPS Growth > 10%
-13.33%

Financial Health Score

Excellent

BLCO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.79
Current Ratio > 1
1.56

Profitability Score

Weak

BLCO struggles to sustain strong margins.

ROE > 15%
-173.15%
Net Margin ≥ 15%
-2.05%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is BLCO Expensive or Cheap?

P/E Ratio

BLCO trades at -68.36 times earnings. This suggests potential undervaluation.

-68.36

PEG Ratio

When adjusting for growth, BLCO's PEG of -0.75 indicates potential undervaluation.

-0.75

Price to Book

The market values Bausch + Lomb Corporation at 1.18 times its book value. This may indicate undervaluation.

1.18

EV/EBITDA

Enterprise value stands at 4.35 times EBITDA. This is generally considered low.

4.35

How Well Does BLCO Make Money?

Net Profit Margin

For every $100 in sales, Bausch + Lomb Corporation keeps $-2.05 as profit after all expenses.

-2.05%

Operating Margin

Core operations generate 8.41 in profit for every $100 in revenue, before interest and taxes.

8.41%

ROE

Management delivers $-1.73 in profit for every $100 of shareholder equity.

-1.73%

ROA

Bausch + Lomb Corporation generates $-0.80 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.80%

Following the Money - Real Cash Generation

Operating Cash Flow

Bausch + Lomb Corporation produces operating cash flow of $552.18M, showing steady but balanced cash generation.

$552.18M

Free Cash Flow

Bausch + Lomb Corporation produces free cash flow of $253.72M, offering steady but limited capital for shareholder returns and expansion.

$253.72M

FCF Per Share

Each share generates $0.71 in free cash annually.

$0.71

FCF Yield

BLCO converts 3.35% of its market value into free cash.

3.35%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-68.36

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.75

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.18

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.40

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.79

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.56

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.02

vs 25 benchmark

ROA

Return on assets percentage

-0.01

vs 25 benchmark

ROCE

Return on capital employed

0.04

vs 25 benchmark

How BLCO Stacks Against Its Sector Peers

MetricBLCO ValueSector AveragePerformance
P/E Ratio-68.3631.30 Better (Cheaper)
ROE-1.73%487.00% Weak
Net Margin-2.05%-1832.00% (disorted) Weak
Debt/Equity0.790.10 Weak (High Leverage)
Current Ratio1.565.74 Neutral
ROA-0.80%-165.00% (disorted) Weak

BLCO outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Bausch + Lomb Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

47.90%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-1878.52%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-46.37%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ